BCM
BIO icon

Bayesian Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bayesian Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,275
Closed -$638K – 162
2025
Q3 		$638K Buy
+2,275
New +$619K 0.13% 233
2024
Q4 		– Sell
-2,262
Closed -$757K – 703
2024
Q3 		$757K Sell
2,262
-1,000
-31% -$318K 0.09% 286
2024
Q2 		$891K Buy
+3,262
New +$949K 0.1% 256
2023
Q4 		– Sell
-7,568
Closed -$2.71M – 760
2023
Q3 		$2.71M Buy
+7,568
New +$2.92M 0.31% 87
2020
Q1 		– Sell
-3,004
Closed -$1.11M – 780
2019
Q4 		$1.11M Sell
3,004
-3,300
-52% -$1.16M 0.19% 162
2019
Q3 		$2.1M Sell
6,304
-2,000
-24% -$652K 0.4% 60
2019
Q2 		$2.6M Buy
8,304
+4,700
+130% +$1.41M 0.54% 41
2019
Q1 		$1.1M Buy
3,604
+900
+33% +$243K 0.21% 147
2018
Q4 		$628K Sell
2,704
-2,278
-46% -$611K 0.13% 237
2018
Q3 		$1.56M Buy
4,982
+3,000
+151% +$931K 0.26% 100
2018
Q2 		$572K Buy
1,982
+844
+74% +$233K 0.13% 232
2018
Q1 		$285K Sell
1,138
-3,315
-74% -$844K 0.07% 409
2017
Q4 		$1.06M Buy
+4,453
New +$1.08M 0.22% 158
2017
Q1 		– Sell
-3,563
Closed -$649K – 418
2016
Q4 		$649K Buy
+3,563
New +$607K 0.16% 244

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bayesian Capital Management's BIO Position: Q4 2025 in Review

Bayesian Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 2,275 shares — an estimated $638K sold.

Bayesian Capital Management first reported a position in BIO in Q4 2016 and held it in 14 quarters. The position peaked at $2.71M in Q3 2023. 398 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

  • Bayesian Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 2,275 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $638K.
  • Bayesian Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 14 quarters.
  • Bayesian Capital Management's Bio-Rad Laboratories Class A position peaked at $2.71M in Q3 2023.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.